Olson Eric R 4
4 · Syros Pharmaceuticals, Inc. · Filed Apr 4, 2022
Insider Transaction Report
Form 4
Olson Eric R
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2022-04-01$1.12/sh−27,266$30,538→ 59,734 total
Footnotes (1)
- [F1]Represents shares used to cover tax withholding on a Restricted Stock Unit release.